Organigram Holdings | OGI - Ebitda



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 155.87M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


Ebitda 更改 日
Acasti Pharma USD -3.01M 562K 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurora Cannabis CAD 3.7M 14.78M 2026-03
Avita Medical AUD -9.69M 12.21M 2025-12
Canopy Growth CAD -137M 134.13M 2026-03
Cronos Group USD -1.41M 1.86M 2026-03
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
IQVIA Holdings USD 994M 62M 2026-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Moderna USD -1.26B 468M 2026-03
Organigram Holdings CAD -4.76M 10.02M 2026-03
Organon & Co USD 371M 44M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1.19B 138.8M 2026-06
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03